Literature DB >> 21292434

Re-resection rates after breast-conserving surgery as a performance indicator: introduction of a case-mix model to allow comparison between Dutch hospitals.

A K Talsma1, A M J Reedijk, R A M Damhuis, P J Westenend, W J Vles.   

Abstract

AIM: Re-resection rate after breast-conserving surgery (BCS) has been introduced as an indicator of quality of surgical treatment in international literature. The present study aims to develop a case-mix model for re-resection rates and to evaluate its performance in comparing results between hospitals.
METHODS: Electronic records of eligible patients diagnosed with in-situ and invasive breast cancer in 2006 and 2007 were derived from 16 hospitals in the Rotterdam Cancer Registry (RCR) (n = 961). A model was built in which prognostic factors for re-resections after BCS were identified and expected re-resection rate could be assessed for hospitals based on their case mix. To illustrate the opportunities of monitoring re-resections over time, after risk adjustment for patient profile, a VLAD chart was drawn for patients in one hospital.
RESULTS: In general three out of every ten women had re-surgery; in about 50% this meant an additive mastectomy. Independent prognostic factors of re-resection after multivariate analysis were histological type, sublocalisation, tumour size, lymph node involvement and multifocal disease. After correction for case mix, one hospital was performing significantly less re-resections compared to the reference hospital. On the other hand, two were performing significantly more re-resections than was expected based on their patient mix.
CONCLUSIONS: Our population-based study confirms earlier reports that re-resection is frequently required after an initial breast-conserving operation. Case-mix models such as the one we constructed can be used to correct for variation between hospitals performances. VLAD charts are valuable tools to monitor quality of care within individual hospitals.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21292434     DOI: 10.1016/j.ejso.2011.01.008

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  16 in total

1.  The Value of Repeated Breast Surgery as a Quality Indicator in Breast Cancer Care.

Authors:  Francesca Tamburelli; Riccardo Ponzone
Journal:  Ann Surg Oncol       Date:  2020-06-10       Impact factor: 5.344

2.  Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.

Authors:  Linnea Langhans; Maj-Britt Jensen; Maj-Lis M Talman; Ilse Vejborg; Niels Kroman; Tove F Tvedskov
Journal:  JAMA Surg       Date:  2017-04-01       Impact factor: 14.766

3.  Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer.

Authors:  Tomofumi Osako; Reiki Nishimura; Yasuyuki Nishiyama; Yasuhiro Okumura; Rumiko Tashima; Masahiro Nakano; Mamiko Fujisue; Yasuo Toyozumi; Nobuyuki Arima
Journal:  Int J Clin Oncol       Date:  2015-04-09       Impact factor: 3.402

4.  Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression.

Authors:  Paul Macklin; Mary E Edgerton; Alastair M Thompson; Vittorio Cristini
Journal:  J Theor Biol       Date:  2012-02-09       Impact factor: 2.691

5.  Intraoperative Pathologic Margin Analysis and Re-Excision to Minimize Reoperation for Patients Undergoing Breast-Conserving Surgery.

Authors:  Jennifer M Racz; Amy E Glasgow; Gary L Keeney; Amy C Degnim; Tina J Hieken; James W Jakub; John C Cheville; Elizabeth B Habermann; Judy C Boughey
Journal:  Ann Surg Oncol       Date:  2020-07-04       Impact factor: 5.344

6.  Reoperation costs in attempted breast-conserving surgery: a decision analysis.

Authors:  R E Pataky; C R Baliski
Journal:  Curr Oncol       Date:  2016-10-25       Impact factor: 3.677

7.  Reoperations after primary breast conserving surgery in women with invasive breast cancer in Catalonia, Spain: a retrospective study.

Authors:  J M Escribà; L Esteban; J Gálvez; M J Pla; A Melià; M Gil-Gil; R Clèries; L Pareja; X Sanz; M Bustins; J M Borrás; J Ribes
Journal:  Clin Transl Oncol       Date:  2016-09-13       Impact factor: 3.405

8.  The Usefulness of Intraoperative Circumferential Frozen-Section Analysis of Lumpectomy Margins in Breast-Conserving Surgery.

Authors:  SeungSang Ko; Yi Kyeong Chun; Sung Soo Kang; Min Hee Hur
Journal:  J Breast Cancer       Date:  2017-06-26       Impact factor: 3.588

9.  Re-Excision Rates in Breast-Conserving Surgery for Invasive Breast Cancer after Neoadjuvant Chemotherapy with and without the Use of a Radiopaque Tissue Transfer and X-ray System.

Authors:  Suniza Jamaris; Leyla Akpolat-Basci; Miltiades Stephanou; Sarah Wetzig; Yueksel Cubuk; Johannes Gerharz; Ann-Kathrin Bittner; Mee Hoong See; Cornelia Liedtke; Hans-Christian Kolberg
Journal:  Breast Care (Basel)       Date:  2018-11-14       Impact factor: 2.860

10.  Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics.

Authors:  R Jeevan; D A Cromwell; M Trivella; G Lawrence; O Kearins; J Pereira; C Sheppard; C M Caddy; J H P van der Meulen
Journal:  BMJ       Date:  2012-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.